BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33130128)

  • 1. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
    Jacobson KA; IJzerman AP; Müller CE
    Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists and antagonists for P2 receptors.
    Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
    Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
    Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
    Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
    Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
    Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
    Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
    J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine and pyrimidine receptors.
    Burnstock G
    Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New paradigms in purinergic receptor ligand discovery.
    Jacobson KA; Pradhan B; Wen Z; Pramanik A
    Neuropharmacology; 2023 Jun; 230():109503. PubMed ID: 36921890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of natural products on p2 receptors: a reinvented era for drug discovery.
    Faria R; Ferreira L; Bezerra R; Frutuoso V; Alves L
    Molecules; 2012 Nov; 17(11):13009-25. PubMed ID: 23117439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of purinergic signaling in cardiovascular diseases.
    Ralevic V; Burnstock G
    Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purines and pain mechanisms: recent developments.
    Liu XJ; Salter MW
    Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.
    Vartian N; Boehm S
    Eur J Neurosci; 2001 Mar; 13(5):899-908. PubMed ID: 11264662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.